ANPCF.US ANGLE plc

Healthcare Biotechnology USA Stocks
0.0098 USD
Close of Nov 13, 2026
0.0098 0.0250
Market cap
USD 11.1M
P/E
-
P/B
2.03x
ROE
-271.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ANPCF.US undervalued?

Graham number

The Graham number of ANGLE plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ANGLE plc fundamental analysis

No fundamental analysis for ANGLE plc yet.

ANGLE plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ANGLE plc

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix platform, emables real-time multiomic insights from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and …

Full company profile